| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±2.5% | -0.5% | over-priced |
| 05/05/2026 | ±3.1% | +2.4% | over-priced |
| 11/06/2025 | ±2.2% | -2.1% | over-priced |
| 08/08/2025 | ±2.4% | +2.0% | over-priced |
| 05/09/2025 | ±2.7% | +5.4% | under-priced |
| 11/08/2024 | ±2.7% | -3.5% | under-priced |
| 08/09/2024 | ±4.3% | +3.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.53 | $2.2B | $92M |
| Q1 FY2026 | $0.07 | $2.0B | $13M |
| Q4 FY2025 | $0.35 | $2.0B | $63M |
| Q3 FY2025 | $7.22 | $2.1B | $1.3B |
Solventum Corporation (SOLV) reports in 75 days, with the next report estimated for 11/26/2026. Across the last 7 reports, options priced an average ±2.9% earnings move while the stock actually moved 2.7% on average — the market has systematically over-priced SOLV's earnings risk. Fundamentals into the print: EPS up 3.9% year-over-year, revenue up 2.2%. QuantLogix's live 5-factor engine currently reads SOLV as a neutral at 49/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →